Key | % Net Assets |
---|---|
Royal Dutch Shell | 9.1% |
BP | 7.8% |
GlaxoSmithKline | 7.8% |
AstraZeneca | 5.2% |
Other | 70.1% |
Name | % Net Assets |
---|---|
Royal Dutch Shell | 9.1% |
BP | 7.8% |
GlaxoSmithKline | 7.8% |
AstraZeneca | 5.2% |
Rio Tinto | 4.1% |
Prudential | 3.0% |
Severn Trent | 3.0% |
Cable & Wireless | 2.9% |
National Grid | 2.7% |
HSBC Holdings | 2.7% |
No asset data available.
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/10/1984 |
---|---|
Fund Manager | Charles Deptford |
TER | 1.51 (31-Jan-2008) |
Minimum Investment | |
---|---|
Initial | 1000 |
Additional | 100 |
Savings | 100 |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.35% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.06 |
You are here: research